COVID-19 Vaccine (Vero Cell), Inactivated, Omicron Strain
Asset
Inactivated Omicron-strain SARS-CoV-2 stimulates protective immune responses against COVID-19.
- Stage
- Phase 2
- Modality
- Vaccine
- Target
- Not known
- 1
- Indication
- 19
- Trials
- 1
- Developer
Indications
1COVID-19
Phase 2, Completed, NCT05411471, clinicaltrials.gov, 10 Oct 2026
In the full profile
- Targets and what it contains1
- Owner and partners1
- Trials19
- Evidence for its targets1
- Competitors1
Every asset’s record: target, stage, trials and the evidence behind it.